Correlation Between Verona Pharma and Atea Pharmaceuticals
Can any of the company-specific risk be diversified away by investing in both Verona Pharma and Atea Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Verona Pharma and Atea Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Verona Pharma PLC and Atea Pharmaceuticals, you can compare the effects of market volatilities on Verona Pharma and Atea Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Verona Pharma with a short position of Atea Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of Verona Pharma and Atea Pharmaceuticals.
Diversification Opportunities for Verona Pharma and Atea Pharmaceuticals
-0.5 | Correlation Coefficient |
Very good diversification
The 3 months correlation between Verona and Atea is -0.5. Overlapping area represents the amount of risk that can be diversified away by holding Verona Pharma PLC and Atea Pharmaceuticals in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Atea Pharmaceuticals and Verona Pharma is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Verona Pharma PLC are associated (or correlated) with Atea Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Atea Pharmaceuticals has no effect on the direction of Verona Pharma i.e., Verona Pharma and Atea Pharmaceuticals go up and down completely randomly.
Pair Corralation between Verona Pharma and Atea Pharmaceuticals
Given the investment horizon of 90 days Verona Pharma PLC is expected to generate 1.21 times more return on investment than Atea Pharmaceuticals. However, Verona Pharma is 1.21 times more volatile than Atea Pharmaceuticals. It trades about 0.11 of its potential returns per unit of risk. Atea Pharmaceuticals is currently generating about 0.03 per unit of risk. If you would invest 1,475 in Verona Pharma PLC on September 4, 2024 and sell it today you would earn a total of 2,436 from holding Verona Pharma PLC or generate 165.15% return on investment over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Against |
Strength | Very Weak |
Accuracy | 100.0% |
Values | Daily Returns |
Verona Pharma PLC vs. Atea Pharmaceuticals
Performance |
Timeline |
Verona Pharma PLC |
Atea Pharmaceuticals |
Verona Pharma and Atea Pharmaceuticals Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Verona Pharma and Atea Pharmaceuticals
The main advantage of trading using opposite Verona Pharma and Atea Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Verona Pharma position performs unexpectedly, Atea Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Atea Pharmaceuticals will offset losses from the drop in Atea Pharmaceuticals' long position.Verona Pharma vs. Crinetics Pharmaceuticals | Verona Pharma vs. Enanta Pharmaceuticals | Verona Pharma vs. Amicus Therapeutics | Verona Pharma vs. Connect Biopharma Holdings |
Atea Pharmaceuticals vs. Immix Biopharma | Atea Pharmaceuticals vs. Cns Pharmaceuticals | Atea Pharmaceuticals vs. Hepion Pharmaceuticals | Atea Pharmaceuticals vs. Enveric Biosciences |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Earnings Calls module to check upcoming earnings announcements updated hourly across public exchanges.
Other Complementary Tools
Technical Analysis Check basic technical indicators and analysis based on most latest market data | |
Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities | |
Money Flow Index Determine momentum by analyzing Money Flow Index and other technical indicators | |
Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
Performance Analysis Check effects of mean-variance optimization against your current asset allocation |